D-0599-2021 Class III Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

FDA drug recall D-0599-2021 was initiated by Dr. Reddy's Laboratories, Inc. on May 4, 2021 and is designated Class III. Reason for recall: Failed Impurities -Degradation Specifications:due to presence of ATV cyclo IP and FP impurities The recall status is terminated (terminated Feb 16, 2023). Affected quantity: 2980 500 count -bottles.

Recall details

Product Type
Drugs
Report Date
Jun 2, 2021
Initiation Date
May 4, 2021
Termination Date
Feb 16, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2980 500 count -bottles

Product description

Atorvastatin Calcium Tablets, USP 10 mg*, Rx Only, 500 count bottle, Mfd By: Dr. Reddy's Laboratories Limited, Bachupally 500 090, India, NDC 55111-121-05.

Reason for recall

Failed Impurities -Degradation Specifications:due to presence of ATV cyclo IP and FP impurities

Distribution pattern

Distributed Nationwide in the USA

Code information

Lot # C905063, Exp 07/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0599-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0599-2021. Report a data issue: hello@regdatalab.com.